These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 7917903

  • 1. Oxygen dependence of the cytotoxicity and metabolic activation of 4-alkylamino-5-nitroquinoline bioreductive drugs.
    Siim BG, Atwell GJ, Wilson WR.
    Br J Cancer; 1994 Oct; 70(4):596-603. PubMed ID: 7917903
    [Abstract] [Full Text] [Related]

  • 2. Metabolic and radiolytic reduction of 4-alkylamino-5-nitroquinoline bioreductive drugs. Relationship to hypoxia-selective cytotoxicity.
    Siim BG, Atwell GJ, Wilson WR.
    Biochem Pharmacol; 1994 Oct 18; 48(8):1593-604. PubMed ID: 7980625
    [Abstract] [Full Text] [Related]

  • 3. Hypoxia-selective antitumor agents. 15. Modification of rate of nitroreduction and extent of lysosomal uptake by polysubstitution of 4-(alkylamino)-5-nitroquinoline bioreductive drugs.
    Siim BG, Atwell GJ, Anderson RF, Wardman P, Pullen SM, Wilson WR, Denny WA.
    J Med Chem; 1997 Apr 25; 40(9):1381-90. PubMed ID: 9135035
    [Abstract] [Full Text] [Related]

  • 4. Efficient redox cycling of nitroquinoline bioreductive drugs due to aerobic nitroreduction in Chinese hamster cells.
    Siim BG, Wilson WR.
    Biochem Pharmacol; 1995 Jun 29; 50(1):75-82. PubMed ID: 7605348
    [Abstract] [Full Text] [Related]

  • 5. Does DNA targeting affect the cytotoxicity and cell uptake of basic nitroquinoline bioreductive drugs?
    Siim BG, Denny WA, Wilson WR.
    Int J Radiat Oncol Biol Phys; 1994 May 15; 29(2):311-5. PubMed ID: 8195025
    [Abstract] [Full Text] [Related]

  • 6. Bis-bioreductive agents as hypoxia-selective cytotoxins: nitracrine N-oxide.
    Wilson WR, Van Zijl P, Denny WA.
    Int J Radiat Oncol Biol Phys; 1992 May 15; 22(4):693-6. PubMed ID: 1544839
    [Abstract] [Full Text] [Related]

  • 7. Exploiting tumor hypoxia through bioreductive release of diffusible cytotoxins: the cobalt(III)-nitrogen mustard complex SN 24771.
    Wilson WR, Moselen JW, Cliffe S, Denny WA, Ware DC.
    Int J Radiat Oncol Biol Phys; 1994 May 15; 29(2):323-7. PubMed ID: 8195027
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. N-[2-(2-methyl-5-nitroimidazolyl)ethyl]-4-(2-nitroimidazolyl)butanamide (NSC 639862), a bisnitroimidazole with enhanced selectivity as a bioreductive drug.
    Moselen JW, Hay MP, Denny WA, Wilson WR.
    Cancer Res; 1995 Feb 01; 55(3):574-80. PubMed ID: 7834627
    [Abstract] [Full Text] [Related]

  • 10. The two faces of aldehyde oxidase: Oxidative and reductive transformations of 5-nitroquinoline.
    Paragas EM, Humphreys SC, Min J, Joswig-Jones CA, Jones JP.
    Biochem Pharmacol; 2017 Dec 01; 145():210-217. PubMed ID: 28888950
    [Abstract] [Full Text] [Related]

  • 11. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J, Oleschuk CJ, Guziec F, Guziec L, Fiterman DJ, Monterrosa C, Begleiter A.
    Cancer Chemother Pharmacol; 2002 Feb 01; 49(2):101-10. PubMed ID: 11862423
    [Abstract] [Full Text] [Related]

  • 12. Hypoxia-selective antitumor agents. 6. 4-(Alkylamino)nitroquinolines: a new class of hypoxia-selective cytotoxins.
    Denny WA, Atwell GJ, Roberts PB, Anderson RF, Boyd M, Lock CJ, Wilson WR.
    J Med Chem; 1992 Dec 25; 35(26):4832-41. PubMed ID: 1479583
    [Abstract] [Full Text] [Related]

  • 13. Caffeine inhibition of the metabolic activation of a carcinogen, 4-nitroquinoline-1-oxide, in cultured Chinese hamster cells.
    Tsuda H, Yoshida D, Mizusaki S.
    Carcinogenesis; 1984 Mar 25; 5(3):331-4. PubMed ID: 6200248
    [Abstract] [Full Text] [Related]

  • 14. The effect of hypoxia on cytotoxicity, accumulation and DNA binding of cisplatin in Chinese hamster ovary cells.
    Matthews JB, Adomat H, Skov KA.
    Anticancer Drugs; 1993 Aug 25; 4(4):463-70. PubMed ID: 8400349
    [Abstract] [Full Text] [Related]

  • 15. Oxygen dependence of the cytotoxicity of the enediyne anti-tumour antibiotic esperamicin A1.
    Batchelder RM, Wilson WR, Hay MP, Denny WA.
    Br J Cancer Suppl; 1996 Jul 25; 27():S52-6. PubMed ID: 8763846
    [Abstract] [Full Text] [Related]

  • 16. Hypoxia-selective antitumor agents. 12. Nitrobenzyl quaternary salts as bioreductive prodrugs of the alkylating agent mechlorethamine.
    Tercel M, Wilson WR, Anderson RF, Denny WA.
    J Med Chem; 1996 Mar 01; 39(5):1084-94. PubMed ID: 8676343
    [Abstract] [Full Text] [Related]

  • 17. Cytotoxicity and DNA lesions produced by mitomycin C and porfiromycin in hypoxic and aerobic EMT6 and Chinese hamster ovary cells.
    Fracasso PM, Sartorelli AC.
    Cancer Res; 1986 Aug 01; 46(8):3939-44. PubMed ID: 3089583
    [Abstract] [Full Text] [Related]

  • 18. Oxygen and exposure kinetics as factors influencing the cytotoxicity of porfiromycin, a mitomycin C analogue, in Chinese hamster ovary cells.
    Marshall RS, Rauth AM.
    Cancer Res; 1988 Oct 15; 48(20):5655-9. PubMed ID: 3167822
    [Abstract] [Full Text] [Related]

  • 19. Relationship between sensitivity of cells from patients with hereditary cutaneous malignant melanoma to killing and mutations by 4-nitroquinoline 1-oxide and adduct formation.
    Sato K, Howell JN, Greene MH, Maher VM, McCormick JJ.
    Cancer Res; 1988 Sep 15; 48(18):5145-50. PubMed ID: 3136916
    [Abstract] [Full Text] [Related]

  • 20. Unusual oxygen concentration dependence of toxicity of SR-4233, a hypoxic cell toxin.
    Koch CJ.
    Cancer Res; 1993 Sep 01; 53(17):3992-7. PubMed ID: 8358728
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.